National health care reporter, Author of the Health 202
Covering coronavirus/Medicaid/states @politico. Are you a frontline health worker? Tell us what you're seeing: bit.ly/2WH2jw3. rroubein@politico.com.
Not enough data
By: Rachel Roubein, Mckenzie Beard
They aggressively questioned the government’s lawyers and the drug company.
By: Colby Itkowitz, Caroline Kitchener, Rachel Roubein
GOP lawmakers in North Carolina and Nebraska are casting new 12-week bans as “mainstream,” while Democrats say they are “cruel and extreme”
By: Rachel Roubein, Mckenzie Beard
Republicans cast 12-week bans as ‘mainstream,’ while Democrats fiercely oppose them
By: Rachel Roubein, Mckenzie Beard
But some medical professionals are expressing concerns about the cost of the medication.
By: Rachel Roubein, Molly Hennessy-Fiske
An earlier effort to tightly restrict abortions in South Carolina was deemed unconstitutional by the state Supreme Court.
By: Mckenzie Beard, Rachel Roubein
The House will consider placing fentanyl-like substances in a category reserved for the most dangerous drugs.
By: Laurie Mcginley, Rachel Roubein
The first drug potentially covered by the expanded plan, Leqembi, could be granted full approval from the Food and Drug Administration as soon as this summer.
By: Mckenzie Beard, Rachel Roubein
Patients will need to be enrolled in registries.
By: Rachel Roubein, Mckenzie Beard, Dan Diamond
The official announcement is likely a week or more away.
By: Mckenzie Beard, Rachel Roubein
The lawsuits argue the bans flout provisions in a state’s constitution, such as bodily autonomy and the freedom for residents to make their own health-care decisions.
(833) 317-6278 
